Delivering Innovative Medical Device Products

“A Value Driven Approach to Medical Device Investments”

MED1 Ventures’ team of world-class medical device experts have developed  and commercialized 80 products that generate over $12B in total revenue and $2.5B in current annual revenue.

Get Access to Our Product Portfolio

Get Access

Delivering Innovative Medical Device Products

“A Value Driven Approach to Medical Device Investments”

MED1 Ventures’ team of world-class medical device experts have developed  and commercialized 80 products that generate over $12B in total revenue and $2.5B in current annual revenue.

Products

Billion Dollars

Get Access to Our Product Portfolio

Get Access

Invests in Products by Thinking Smaller and
Winning Faster for Investors & Inventors

What is MED1?

MED1 is focused on our skill set of product development execution on products that meet targeted market unmet needs with fully identified acquisition partners in the ophthalmic and women’s health space.

MED1 Difference

90-rightdown

We Develop Products
Not Invest in Infrastructure

  • World Class Development, Business, Medical & Professional Team
  • Proven Strategic Assessment Process (+80% Commercial Success)
  • Robust Global Market Focus
  • Products Ready for Investment
needle

Think Smaller. Win Faster!

  • 18 to 48 Month Product Exit Focus
  • QSBS Tax Advantage
  • Investor Ability to Choose Investments
  • Investor, Acquirer & Inventor Friendly
  • Portfolio Products Under Evaluation

90-leftup

MED1 Difference

We Develop Products

Not Invest in Infrastructure

  • World Class Development, Business, Medical & Professional Team
  • Proven Strategic Assessment Process (+80% Commercial Success)
  • Robust Global Market Focus
  • Products Ready for Investment

Think Smaller. Win Faster!

  • 18 to 48 Month Product Exit Focus
  • QSBS Tax Advantage
  • Investor Ability to Choose Investments
  • Investor, Acquirer & Inventor Friendly
  • Portfolio of Products Under Evaluation
needle

MED1 Risk Mitigation Approach

  • Focused on products with 18 to 48 months exits
  • $1M to $10M investment
  • Minimum 3X target return on product exits
  • World Class Development, Business, Medical & Professional Team
  • IP protected portfolio products with High Gross Margin facilitates attractive exits
process-01

MED1’s Investor Friendly Approach

90-rightdown

$2.5M

Investment

2yrs

Est. Exit

center

$10m
Exit Price

90-leftup

Investment Example and refer to MED1’s Product C-Corp Prospectus and is Qualified in Its Entirety By Reference To Such Documents.

MED1 Risk Mitigation Approach

  • Focused on products with 18 to 48 months exits
  • $1M to $10M investment with up to $40M exit potential
  • 3X target cash return on portfolio project investments
  • World Class Development, Business, Medical & Professional Team
  • IP protected portfolio products with High Gross Margin facilitates attractive exits

MED1’s
Investor Friendly Approach

process-01

90-rightdown

$2.5m

Investment

2 yrs

Est. Exit

center

$10m
Exit Price

90-leftup

Investment Example and refer to MED1’s Private Placement Memorandum and Limited Partnership Agreement and is Qualified In Its Entirety By Reference To Such Documents.

Leadership

Leadership

Duane Lee
Duane Lee

Duane Lee
Managing Partner Greater China & SE Asia

Mr. Lee has more than 25 years in the healthcare and medical device industry in Asia. He has 10+ years experiences with top multinational medical device companies as the General Manager of Greater China and Asia.  Duane in 1997 founded and built a several hundred-million-dollar Chinese business, taking the company public on the Taipei Exchange. Duane’s expertise and background in marketing and sales with medical devices covers Bio-Research, IVD, Radiation Oncology, and Ophthalmology and has successfully launched these technologies and products in Asia.
Tim Willis
Tim Willis

Tim Willis
CEO & Founder

Mr. Willis is a Founding Partner of MED1 Ventures. Tim has more than 30 years of ophthalmology industry experience having founded or help found 8 companies. Tim is a seasoned business executive and entrepreneur and inventor having raised $195 million in funding, over 30 issued patents, and responsible for the development and launch of 55 ophthalmic products that today represent over one and half billion dollars in annual sales.
Steve Bacich
Steve Bacich

Steve Bacich
CTO & Founder

Mr. Bacich is the Chief Technology Officer and Founding Partner of MED1 Ventures. Steve has more than 20 year of medical device industry experience with over 15 years focused on women’s health. Mr. Bacich completed several venture and public funding rounds in total raising over $250 million. Steve has over 50 issued US medical device patents and has brought over 25 products to market.

Kent Geer
Kent Geer

Kent Geer
Managing Director Finance & Investor Relations

Mr. Geer is a former partner with Ernst & Young. Kent has more than 30 years of experience and track record serving numerous public and private companies in a variety of industries including biotechnology, medical device, pharmaceuticals and other technology companies. During his tenure, Mr. Geer was the audit practice leader for Ernst & Young Entrepreneurial Services Group and was the market team leader for the technology industry practice.
Diethart Reichardt
Diethart Reichardt

Diethart Reichardt
International Business Development

Mr. Reichardt is a business executive with over 35 years of experience in sales, marketing, and European business and general management expertise. Diethart has served in leadership positions for several global medical device and pharmaceutical companies in ophthalmology and women’s health.

MED1 Partners

Interested in Investing or Working with us?

Request an Investor/Inventor Presentation

Whether you are an investor or inventor, we can help your achieve your goals. Contact us today.

Med1 Ventures LLC.

Raleigh, NC
San Francisco, CA
Shanghai, China
Karlsruhe, Germany

Contact
Call 919.241.3200
Email [email protected]

Follow Us